157 related articles for article (PubMed ID: 34933375)
1. Pulmonary Hypertension and COVID-19.
Castiglione L; Droppa M
Hamostaseologie; 2022 Aug; 42(4):230-238. PubMed ID: 34933375
[TBL] [Abstract][Full Text] [Related]
2. An Update on Pulmonary Hypertension in Coronavirus Disease-19 (COVID-19).
Mishra A; Lal A; Sahu KK; George AA; Martin K; Sargent J
Acta Biomed; 2020 Nov; 91(4):e2020155. PubMed ID: 33525228
[TBL] [Abstract][Full Text] [Related]
3. COVID-19 in Patients with Pulmonary Hypertension: A National Prospective Cohort Study.
Montani D; Certain MC; Weatherald J; Jaïs X; Bulifon S; Noel-Savina E; Nieves A; Renard S; Traclet J; Bouvaist H; Riou M; de Groote P; Moceri P; Bertoletti L; Favrolt N; Guillaumot A; Jutant EM; Beurnier A; Boucly A; Ebstein N; Jevnikar M; Pichon J; Keddache S; Preda M; Roche A; Solinas S; Seferian A; Reynaud-Gaubert M; Cottin V; Savale L; Humbert M; Sitbon O;
Am J Respir Crit Care Med; 2022 Sep; 206(5):573-583. PubMed ID: 35549842
[No Abstract] [Full Text] [Related]
4. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
5. A prospective, randomized, crossover pilot study of inhaled nitric oxide versus inhaled prostacyclin in heart transplant and lung transplant recipients.
Khan TA; Schnickel G; Ross D; Bastani S; Laks H; Esmailian F; Marelli D; Beygui R; Shemin R; Watson L; Vartapetian I; Ardehali A
J Thorac Cardiovasc Surg; 2009 Dec; 138(6):1417-24. PubMed ID: 19931670
[TBL] [Abstract][Full Text] [Related]
6. [Once in a blue moon: coronavirus disease complicates pregnancy in a patient with unknown pulmonary hypertension and subsequent left ventricular dysfunction].
Giraldo-Ramírez S; Gándara-Ricardo JA; Velasquez-Penagos J; Flórez-Muñoz J; Muñoz-Ortiz E
Arch Cardiol Mex; 2023 Sep; 93(Supl 6):134-136. PubMed ID: 37669622
[TBL] [Abstract][Full Text] [Related]
7. Acute pulmonary hypertension and short-term outcomes in severe Covid-19 patients needing intensive care.
Norderfeldt J; Liliequist A; Frostell C; Adding C; Agvald P; Eriksson M; Lönnqvist PA
Acta Anaesthesiol Scand; 2021 Jul; 65(6):761-769. PubMed ID: 33728633
[TBL] [Abstract][Full Text] [Related]
8. COVID-19 Patients With Pulmonary Hypertension Hospitalized in the United States During the Early Pandemic: Analysis of In-Hospital Mortality, Clinical Outcomes, and Racial Disparities.
Majeed H; Cannon HR; Raj K; Nasrullah A; Majeed S; Gangu K; Farooq A; Sheikh AB
Curr Probl Cardiol; 2023 Nov; 48(11):101933. PubMed ID: 37422043
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of Pulmonary Vasculopathy in Acute and Long-Term COVID-19: A Review.
Riou M; Coste F; Meyer A; Enache I; Talha S; Charloux A; Reboul C; Geny B
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732160
[TBL] [Abstract][Full Text] [Related]
10. Inhaled prostacyclin is safe, effective, and affordable in patients with pulmonary hypertension, right heart dysfunction, and refractory hypoxemia after cardiothoracic surgery.
De Wet CJ; Affleck DG; Jacobsohn E; Avidan MS; Tymkew H; Hill LL; Zanaboni PB; Moazami N; Smith JR
J Thorac Cardiovasc Surg; 2004 Apr; 127(4):1058-67. PubMed ID: 15052203
[TBL] [Abstract][Full Text] [Related]
11. [Six cases of acute pulmonary embolism associated with COVID-19].
Steeman A; Mazairac G; Kirsch L; Frusch N; Morandini E; Benoit A
Rev Med Liege; 2020 Sup; 75(S1):94-100. PubMed ID: 33211429
[TBL] [Abstract][Full Text] [Related]
12. Inhaled nitric oxide versus inhaled prostacyclin and intravenous versus inhaled prostacyclin in acute respiratory failure with pulmonary hypertension in piglets.
Zobel G; Dacar D; Rödl S; Friehs I
Pediatr Res; 1995 Aug; 38(2):198-204. PubMed ID: 7478816
[TBL] [Abstract][Full Text] [Related]
13. Thromboembolic Complications in Severe COVID-19: Current Antithrombotic Strategies and Future Perspectives.
Rodriguez JJ; Munoz OC; Porres-Aguilar M; Mukherjee D
Cardiovasc Hematol Disord Drug Targets; 2021; 21(1):23-29. PubMed ID: 33719953
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide as a double-edged sword in pulmonary viral infections: Mechanistic insights and potential therapeutic implications.
Masood M; Singh P; Hariss D; Khan F; Yameen D; Siraj S; Islam A; Dohare R; Mahfuzul Haque M
Gene; 2024 Mar; 899():148148. PubMed ID: 38191100
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide is superior to prostacyclin for pulmonary hypertension after cardiac operations.
Goldman AP; Delius RE; Deanfield JE; Macrae DJ
Ann Thorac Surg; 1995 Aug; 60(2):300-5; discussion 306. PubMed ID: 7646090
[TBL] [Abstract][Full Text] [Related]
16. One year of COVID-19 pandemic: what we Radiologists have learned about imaging.
Gross A; Albrecht T
Rofo; 2022 Feb; 194(2):141-151. PubMed ID: 34649291
[TBL] [Abstract][Full Text] [Related]
17. Aerosolized prostacyclin and iloprost in severe pulmonary hypertension.
Olschewski H; Walmrath D; Schermuly R; Ghofrani A; Grimminger F; Seeger W
Ann Intern Med; 1996 May; 124(9):820-4. PubMed ID: 8610951
[TBL] [Abstract][Full Text] [Related]
18. Inhaled prostacyclin, nitric oxide, and nitroprusside in pulmonary hypertension after mitral valve replacement.
Fattouch K; Sbraga F; Bianco G; Speziale G; Gucciardo M; Sampognaro R; Ruvolo G
J Card Surg; 2005; 20(2):171-6. PubMed ID: 15725144
[TBL] [Abstract][Full Text] [Related]
19. COVID-19 and Pulmonary Hypertension in Children: What Do We Know So Far?
Das BB
Medicina (Kaunas); 2020 Dec; 56(12):. PubMed ID: 33352654
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary Hypertension in Heart Failure. Epidemiology, Right Ventricular Function, and Survival.
Gerges M; Gerges C; Pistritto AM; Lang MB; Trip P; Jakowitsch J; Binder T; Lang IM
Am J Respir Crit Care Med; 2015 Nov; 192(10):1234-46. PubMed ID: 26181215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
